TVIS44028079
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
80882346 |
80882346 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028080
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
81374787 |
81374787 |
q21.1 |
ENSG00000296721 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028081
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
82092120 |
82092120 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028082
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
82594953 |
82594953 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028083
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
84769714 |
84769714 |
q21.1 |
ENSG00000309030 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028084
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
8730418 |
8730418 |
p22.31 |
ANOS1 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028085
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
87404873 |
87404873 |
q21.31 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028086
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
88189827 |
88189827 |
q21.31 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028087
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
90978671 |
90978671 |
q21.31 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
TVIS44028088
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chrX |
92252305 |
92252305 |
q21.31 |
PCDH11X |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |